128 related articles for article (PubMed ID: 1867098)
1. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases.
Song B
Acta Pathol Jpn; 1991 May; 41(5):336-43. PubMed ID: 1867098
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors].
Yane K; Tanaka O; Miyahara H; Matsunaga T; Kitahori Y; Hiasa Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 May; 96(5):787-90. PubMed ID: 8315535
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors].
Cabaret V; Vilain MO; Delobelle-Deroide A; Vanseymortier L
Ann Pathol; 1992; 12(6):347-52. PubMed ID: 1294156
[TBL] [Abstract][Full Text] [Related]
4. EGF-receptors in human normal and pathological thyroid tissue.
Westermark K; Lundqvist M; Wallin G; Dahlman T; Hacker GW; Heldin NE; Grimelius L
Histopathology; 1996 Mar; 28(3):221-7. PubMed ID: 8729040
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.
Kodama M; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670
[TBL] [Abstract][Full Text] [Related]
6. [HBME-1 immunostaining in thyroid pathology].
Rigau V; Martel B; Evrard C; Rousselot P; Galateau-Salle F
Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556
[TBL] [Abstract][Full Text] [Related]
7. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
Shingu K; Fujimori M; Ito K; Hama Y; Kasuga Y; Kobayashi S; Itoh N; Amano J
Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases.
Kondi-Pafiti A; Smyrniotis V; Frangou M; Papayanopoulou A; Englezou M; Deligeorgi H
Acta Oncol; 2000; 39(6):753-6. PubMed ID: 11130016
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.
Tuccari G; Barresi G
Histopathology; 1987 Jul; 11(7):723-31. PubMed ID: 3623436
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Kavishwar VS; Phatak AM; Rege JD
Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
Stefăneanu L; Simionescu L; Aman E; Taşcă C
Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases.
Stefăneanu L; Taşcă C
Acta Histochem; 1986; 78(1):7-18. PubMed ID: 2421518
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin.
Vaideeswar P; Pandit AA; Khilnani PH; Powar HS
Indian J Pathol Microbiol; 1994 Apr; 37(2):165-9. PubMed ID: 7959983
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen receptors in the malignant and benign neoplasms of the thyroid].
Lewy-Trenda I
Pol Merkur Lekarski; 1998 Aug; 5(26):80-3. PubMed ID: 10101461
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
[TBL] [Abstract][Full Text] [Related]
17. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
18. Value of immunoperoxidase staining of thyroglobulin in fine needle aspiration cytology of thyroid diseases.
Tung CC; Chang TC; Hsieh HC
Acta Cytol; 1995; 39(3):396-401. PubMed ID: 7539201
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.
Cvejić D; Savin S; Petrović I; Paunović I; Tatić S; Havelka M
Acta Chir Iugosl; 2003; 50(3):67-70. PubMed ID: 15179758
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.
Aratake Y; Kotani T; Tamura K; Araki Y; Kuribayashi T; Konoe K; Ohtaki S
Am J Clin Pathol; 1991 Sep; 96(3):306-10. PubMed ID: 1715126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
